Association between prenatal exposure to antipsychotics and attention-deficit/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational age
JAMA Aug 20, 2021
Wang Z, Chan AYL, Coghill D, et al. - Prenatal exposure to antipsychotics is suggested to have no correlation with attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), preterm birth (< 37 gestational weeks), and small for gestational age (birth weight < 2 standard deviations below the mean for gestational age). However, there may be a correlation of underlying maternal psychiatric disorders with the risk of ADHD and ASD in children.
From the Hong Kong Clinical Data Analysis and Reporting System, researchers retrieved data of children born between January 2001 and January 2015 with follow-up to December 2019 for this population-based cohort study.
This cohort study included 411,251 mother-child pairs.
Prenatal use of antipsychotics did not link with an increased risk of ADHD, ASD, preterm birth, and small for gestational age.
A significantly increased risk of ADHD and ASD was evident in correlation with maternal psychiatric disorders.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries